Ps0007 50168 — Chicago, Illinois

Ps0007 50168 is a clinical research site located in Chicago, Illinois, United States 60611.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Ps0007 50168 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Moderate Chronic Plaque Psoriasis, Severe Chronic Plaque Psoriasis, Mixed Guttate/Plaque Psoriasis.

Sponsors: UCB Biopharma SRL.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Ps0007 50168?

Ps0007 50168 has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Ps0007 50168 conducted?

Ps0007 50168 has 1 clinical trials on record, with 1 currently active. Their work covers Moderate Chronic Plaque Psoriasis, Severe Chronic Plaque Psoriasis, Mixed Guttate/Plaque Psoriasis.

Is Ps0007 50168 accredited by Crixeo Health?

Ps0007 50168 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Ps0007 50168?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.